Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review.

Autor: Zheng H; Department of Biomedical Sciences, University of Sassari, 07100, Sassari, Italy.; Department of Cardiology, The Second Affiliated Hospital of Shantou University Medical College, 515041, Shantou, China., Sechi LA; Department of Biomedical Sciences, University of Sassari, 07100, Sassari, Italy.; Complex Structure of Microbiology and Virology, AOU Sassari, 07100, Sassari, Italy., Navarese EP; Clinical and Experimental Cardiology, Clinical and Interventional Cardiology, University of Sassari, Sassari, Italy., Casu G; Clinical and Experimental Cardiology, Clinical and Interventional Cardiology, University of Sassari, Sassari, Italy., Vidili G; Department of Medicine, Surgery, and Pharmacy, University of Sassari, Azienda Ospedaliero, 07100, Sassari, Italy. gvidili@uniss.it.
Jazyk: angličtina
Zdroj: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Sep 28; Vol. 23 (1), pp. 346. Date of Electronic Publication: 2024 Sep 28.
DOI: 10.1186/s12933-024-02434-5
Abstrakt: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed nonalcoholic fatty liver disease (NAFLD), poses a significant global health challenge due to its increasing prevalence and strong association with cardiovascular disease (CVD). This comprehensive review summarizes the current knowledge on the MASLD-CVD relationship, compares analysis of how different terminologies for fatty liver disease affect cardiovascular (CV) risk assessment using different diagnostic criteria, explores the pathophysiological mechanisms connecting MASLD to CVD, the influence of MASLD on traditional CV risk factors, the role of noninvasive imaging techniques and biomarkers in the assessment of CV risk in patients with MASLD, and the implications for clinical management and prevention strategies. By incorporating current research and clinical guidelines, this review provides a comprehensive overview of the complex interplay between MASLD and cardiovascular health.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje